Organized By

Wellcome Note

The European Society for Translational Medicine (EUSTM) cordially invites you to attend the Immunotherapeutics 2023 Congress (From Biology to Patient Care) which will be held in virtual format during 6-7 May, 2023.

The Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, & vaccines covering from biological research, diagnostics & biomarkers to clinical care.

The Congress not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed side of immunotherapies for cancer and infectious diseases, but also an avenue for global networking with stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.

We look forward to welcome you.

Sincerely,

Congress Co-Chairs

Latest News & Developments

CPD/CME Points Accreditation

CPD/CME points Accreditation will be applied to the Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians of the UK.

Abstracts Submission will be opened from 15th December, 2022 till 15th February, 2023 for the Immunotherapeutics 2023Congress

EUSTM Organizing committee has announced today to open the Abstracts Submission for the Immunotherapeutics 2023 Congress from 15th December 2022 till 15th Feb. 2023.

EUSTM announced the date for the Immunotherapeutics 2023 Congress

EUSTM is sincerely grateful to 4200 Plus global Attendees at EUSTM-2022 Congress

Congress Sponsors